Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 48 Multiple Myeloma 39 Lymphoma, Large B-Cell, Diffuse 38 Burkitt Lymphoma 34 Lymphoma 31 Leukemia, Myeloid, Acute 31 Lymphoma, Non-Hodgkin 29 Recurrence 27 Breast Neoplasms 27 Neoplasms 23 Lymphoma, B-Cell 23 Myelodysplastic Syndromes 22 Leukemia, Lymphocytic, Chronic, B-Cell 22 Lymphoma, Follicular 20 Hodgkin Disease 18 Triple Negative Breast Neoplasms 17 Melanoma 17 Leukemia 17 Ovarian Neoplasms 16 Hematologic Neoplasms 15 Neuroblastoma 14 Lymphoma, Mantle-Cell 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12 Pancreatic Neoplasms 12 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12 Leukemia, Biphenotypic, Acute 11 Neoplasm Metastasis 10 Lymphoma, B-Cell, Marginal Zone 10 Leukemia, Myelomonocytic, Chronic 10 Sarcoma 9

Interventions

Vinblastine 1 Nivolumab 1 Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Childhood Solid Tumor × Cyclophosphamide × 90 days × Clear all

NCT03585465 2026-05-29

Metro-PD1

Centre Oscar Lambret

Phase 1/2 Terminated

Other solid neoplasm

Childhood Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡